[CHRS] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
23-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -18.68%
YoY- -571.00%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 45,424 60,151 60,115 73,371 82,503 87,643 83,034 -33.08%
PBT -86,650 -50,150 -96,084 -45,725 -38,528 -29,900 -172,947 -36.89%
Tax 6,201 6,137 15,159 5,793 5,801 5,758 5,709 5.66%
NP -92,851 -56,287 -111,243 -45,725 -38,528 -29,900 -172,947 -33.91%
Tax Rate - - - - - - - -
Total Cost 138,275 116,438 171,358 119,096 121,031 117,543 255,981 -33.64%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -204.41 -93.58 -185.05 -62.32 -46.70 -34.12 -208.28 -1.24%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -1.19 -0.73 -1.44 -0.60 -0.49 -0.40 -2.37 -36.80%
EPS Diluted -1.19 -0.73 -1.44 -0.60 -0.49 -0.40 -2.37 -36.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.